Want to join the conversation?
$PFE will pay $550MM to AstraZeneca upon deal close and will make a $175MM deferred payment in Jan. 2019. AstraZeneca is also eligible to receive up to $250MM in milestone payments, up to $600MM in sales-related payments, and tiered royalties on sales of Zavicefta and ATM-AVI in some markets. Deal is not expected to impact $PFE's 2016 guidance.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)